• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

This Value Move May Have Legs

These stocks could rally for days without running into valuation ceilings.
By JIM CRAMER Mar 25, 2014 | 03:38 PM EDT
Stocks quotes in this article: CAT, CSX, CELG, JNJ, URI

Value matters. Value is playing a role. Long-term value is springing up everywhere -- just as I wish the real spring season would make itself known.

I know, it seems that I am being facetious. Doesn't the market always care about value? But the simple answer is no. There are plenty of times that the predominate investors -- who are all we really care about because they move stocks -- only care about growth. Value gets ignored because value doesn't move unless someone tries to bring value out. But growth? Growth rolls higher.

Over the last week, a transference has occurred. The aggressive buyers are seeing value if the economy gets better, and they are taking no prisoners as they buy stocks.

Let's go over a couple of value names and you will see what I mean. First, there's Caterpillar (CAT), which is one of the best stocks in the entire market. Caterpillar has been a chronic underperformer for several years, mostly because it has consistently missed earnings estimates. In the meantime, the stock market as a whole has gotten very expensive relative to Caterpillar. Right now, Caterpillar's trading at about 14x heavily reduced earnings estimates. That's much lower than the 17.2x earnings of the S&P 500.

Now, until recently that meant nothing. Who cares about value if you can buy a stock like Twitter (TWTR) that keeps going higher? Why bother with value when Chipotle (CMG) is steaming ahead? But now those admittedly expensive stocks are going down and the growth buyers are either flummoxed or reaching for initial public offerings (IPOs) -- as I will discuss later.

Now , though, we have to recognize that there are things that can not only go wrong with Caterpillar but also go right. Consider these three positives. First, we had United Rentals (URI) on Mad Money not that long ago and it is the biggest buyer of Caterpillar products. We know from Mike Kneeland, the United Rentals CEO, that his order book is brimming and that the optimism for commercial construction, which is what Caterpillar is all about, is seeing a renaissance.

Next, consider the Fed's comments last week. The Fed is saying that business is getting better and that means there is going to be a need for non-residential building. That's right in Caterpillar's wheelhouse.

Plus, we have been hearing a lot of calls about how coal has at last bottomed out. If you recall, Michael Ward, the CEO of coal-hauler CSX (CSX) told us recently. The action in Joy Global (JOY), the biggest stand-alone coal equipment company, rallied big today. We know that Caterpillar is Joy's biggest competitor. A bottom in coal means big numbers for Caterpillar.

Finally, all over the Street today we heard about a revival in trucking, for the first time in ages. Caterpillar makes engines, so you can't have a rally in trucking without it benefiting Caterpillar.

So, the stock runs with the idea that even if it screws up, how much more can the stock fall? After all, it reported a hideous number last time and the stock didn't go down. What if it reports a good one? The stock will certainly be trading much higher than it is now.

Second, how about looking at a value play? Johnson & Johnson (JNJ) is my favorite large-capitalization pharmaceutical name. This company has the highest growth rate of all the major pharmaceuticals, yet it has done nothing, nothing at all since it reported a good quarter but gave lukewarm guidance. The stock has since languished in the wilderness and is actually trading at a discount to the average stock in the S&P.

Value buyers know that disparity can't last: It is the fastest growing major drug company, with the best balance sheet of any company in the U.S. and the best management in CEO Alex Gorsky -- who has talked openly about shaking the company up to have only top-tier divisions -- and yet the stock trades at a discount to the rest of the market. That's preposterous. But as the money poured out of the speculative biotechs in the last few days, it has come back to Johnson & Johnson.

Then there's IBM (IBM), which I praised yesterday. Without a single whisper of analyst love, the stock is ramping like I haven't seen in years.

How can it rally like this on nothing? Same as Caterpillar: It got too darned cheap. Yes, IBM missed the last quarter, but the company is rapidly transitioning to the cloud. It is much more of a software than a hardware company. Yet it sells for 10x earnings -- not revenues but earnings. Again, I know that IBM, like Caterpillar, hasn't made the numbers. However, at 10x earnings with a new mainframe cycle coming and oodles of cash flow, the value guys are saying, who cares? The stock is too cheap.

Then there's Microsoft (MSFT), which hit a 52-week high today in part because it is going to spell out its new strategy on March 27. I think that the company's new CEO, Satya Nadella, will usher in a new era of glasnost in which everything is on the table. No sacred cows. That alone could take this stock, which is trading at 14x earnings and yielding almost 3%, still higher. By the way, this is the same logic that has quietly produced a stealth move higher in Apple (AAPL), which is another stock that is selling at 12x earnings. The only differences are that Apple has a slower growth rate and a shareholder base that is frustrated and restive.

Or how about Schlumberger (SLB)? This company also got left behind by the market. This is the finest oil service company in the world with the best technology and the best minds. I have seen this stock trade at a premium to the S&P for ages. But of late, because of some tepid guidance, it has slipped to become a discount stock. That ended today when management spoke at that Howard Weil conference I talked about. They gave a tremendous outlook that shows we really are in a golden age for drilling. They used the fabled "strong year-over-year growth" line that really gets stocks going -- and it sure did, as the stock has roared all day from the get-go.

Finally , you want a totally wild one? You know what hit my value screen today? Are you ready skidaddy? Celgene (CELG). Yes, the biotech stock that today hit $142 is down a staggering 32 points from the high. Here's a shocker: Did you know that at $142 Celgene is now dramatically cheaper in 2016 earnings than Pfizer (PFE) or Merck (MRK)? Can you imagine? A company with the kind of growth that Celgene has is trading at a discount to two slow-growing behemoths? When I put pen to paper, I couldn't believe it that it could be that cheap. But when stocks get hit as hard as Celgene has, you get some real value. That's why the trust had to go in and buy some more even as it paid too much not long ago.

Now, I know there are still plenty of pockets of overvaluation. Plenty of reckless IPOs. Plenty of hyped fuel-cell and marijuana stocks, as well as too many newly minted Software as a Service (SaaS) companies and development stage biotechs that will never develop.

Yep, right now, the value money managers are stepping up and taking stocks while the growth managers are licking their wounds. Now here's the bottom line: This value move may have some real legs. The stocks they are taking up are so much cheaper than the average equity that they could rally for days without running into valuation ceilings.

True, they have now run a bit. But only a miser a real Scrooge McDuck would think they are too expensive.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Action Alerts PLUS,  which Cramer co-manages as a charitable trust, is long AAPL. CELG. CSX and JNJ.

TAGS: Investing | U.S. Equity | Stocks

More from Stocks

Dare I Recommend a Retail Name Like American Eagle Outfitters?

Bruce Kamich
May 23, 2022 3:15 PM EDT

Let's check out the charts.

Gravity Is Pulling on Apple

Mark Sebastian
May 23, 2022 2:32 PM EDT

Here's where I see AAPL going and how to play it.

Look for General Motors Shares to Restart Their Uptrend

Bruce Kamich
May 23, 2022 2:10 PM EDT

Why aggressive traders could get behind the GM wheel again.

Alibaba Is Sold out on the Downside

Bruce Kamich
May 23, 2022 1:26 PM EDT

China at a bearish extreme is an opportunity.

It 'Bears' Repeating: Tune Out the Noise!

Bob Lang
May 23, 2022 1:16 PM EDT

The noise around the markets is loud, distracting and sometimes obnoxious, but if you listen to it, you'll end up making poor decisions.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:24 PM EDT PAUL PRICE

    An Interesting Chart

    I'm betting heavily that stocks will be way up aga...
  • 10:10 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "Market Timing for Dummies"
  • 01:44 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10 Portfolio

    We're making a series of trades here.
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login